253 related articles for article (PubMed ID: 24333061)
41. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations.
Phikulsod S; Oota S; Tirawatnapong T; Sakuldamrongpanich T; Chalermchan W; Louisirirotchanakul S; Tanprasert S; Chongkolwatana V; Kitpoka P; Phanuphak P; Wasi C; Nuchprayoon C;
Transfusion; 2009 Jun; 49(6):1126-35. PubMed ID: 19392770
[TBL] [Abstract][Full Text] [Related]
42. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
[TBL] [Abstract][Full Text] [Related]
43. A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections.
Vermeulen M; van Drimmelen H; Coleman C; Mitchel J; Reddy R; Lelie N
Transfusion; 2014 Oct; 54(10):2496-504. PubMed ID: 24749834
[TBL] [Abstract][Full Text] [Related]
44. Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety.
Kumar R; Gupta S; Kaur A; Gupta M
Asian J Transfus Sci; 2015; 9(2):199-202. PubMed ID: 26420945
[TBL] [Abstract][Full Text] [Related]
45. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
[TBL] [Abstract][Full Text] [Related]
46. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.
Makroo RN; Choudhury N; Jagannathan L; Parihar-Malhotra M; Raina V; Chaudhary RK; Marwaha N; Bhatia NK; Ganguly AK
Indian J Med Res; 2008 Feb; 127(2):140-7. PubMed ID: 18403791
[TBL] [Abstract][Full Text] [Related]
47. Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.
Yang Z; Xu L; Liu L; Feng Q; Zhang L; Ma W; Saldanha J; Wang M; Zhao L
Transfusion; 2013 Oct; 53(10 Pt 2):2538-44. PubMed ID: 23480568
[TBL] [Abstract][Full Text] [Related]
48. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
Stramer SL; Notari EP; Krysztof DE; Dodd RY
Transfusion; 2013 Oct; 53(10 Pt 2):2449-58. PubMed ID: 23607261
[TBL] [Abstract][Full Text] [Related]
49. Nucleic acid amplification test: Bridging the gap in blood safety & re-evaluation of blood screening for cryptic transfusion-transmitted infection among Indian donors.
Datta S; Khillan K; Ranjan V; Wattal C
Indian J Med Res; 2019 Mar; 149(3):389-395. PubMed ID: 31249205
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive analysis of hepatitis B virus infections in blood donors in southern China that are surface antigen positive but nucleic acid testing negative.
Ye X; Li T; Zhang R; Liu H; Zeng J; Hong W; Lu L; Zhu W; Li S; Xu M; Wu S; Chen L
Transfusion; 2020 Jul; 60(7):1476-1482. PubMed ID: 32358842
[TBL] [Abstract][Full Text] [Related]
51. Use of supplemental anti-HBc testing of donors showing non-discriminating reactive results in multiplex nucleic acid testing.
Kang JW; Seo JH; Youn KW; Seo YI; Huh K; Choi GR; Min HK; Oh DJ; Jo HJ; Kim JN
Vox Sang; 2017 Oct; 112(7):622-627. PubMed ID: 28891069
[TBL] [Abstract][Full Text] [Related]
52. Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System.
Xiao X; Zhai J; Zeng J; Tian C; Wu H; Yu Y
J Virol Methods; 2013 Feb; 187(2):357-61. PubMed ID: 23142222
[TBL] [Abstract][Full Text] [Related]
53. Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia.
Safic Stanic H; Babic I; Maslovic M; Dogic V; Bingulac-Popovic J; Miletic M; Jurakovic-Loncar N; Vuk T; Strauss-Patko M; Jukic I
Transfus Med Hemother; 2017 Nov; 44(6):415-420. PubMed ID: 29344018
[TBL] [Abstract][Full Text] [Related]
54. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the Procleix Ultrio Plus ID NAT assay for detection of HIV 1, HBV and HCV in blood donors.
Makroo RN; Chowdhry M; Bhatia A; Antony M
Asian J Transfus Sci; 2015; 9(1):29-30. PubMed ID: 25722569
[TBL] [Abstract][Full Text] [Related]
56. The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitis C virus, and human immunodeficiency virus.
Guo Z; Fu P; Yin Y; Wang F; Yin Y; Wang J; Liu Y
Transfusion; 2017 Mar; 57(3pt2):832-840. PubMed ID: 28164313
[TBL] [Abstract][Full Text] [Related]
57. Clinical performance of a new multiplex assay for the detection of HIV-1, HIV-2, HCV, HBV, and HEV in blood donations in Catalonia (Spain).
Sauleda S; Bes M; Piron M; Ong E; Coco SB; Carrió J; Linnen JM
Transfusion; 2023 Nov; 63(11):2098-2105. PubMed ID: 37767741
[TBL] [Abstract][Full Text] [Related]
58. Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country.
Stolz M; Gowland P; Tinguely C; Niederhauser C
Transfus Med Hemother; 2019 Apr; 46(2):104-110. PubMed ID: 31191196
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
60. Molecular characteristics of HBV infection among blood donors tested HBsAg reactive in a single ELISA test in southern China.
Ye X; Li T; Li R; Liu H; Zhao J; Zeng J
BMC Infect Dis; 2021 Jan; 21(1):83. PubMed ID: 33468062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
